NCT05689359 2024-03-08
Evaluation of Hydroxychloroquine to Prevent CIPN
University of Arizona
Phase 2 Withdrawn
Clinical Trials
4 trialsNCT04675450 2023-06-08
NBP in Women With Metastatic Breast Cancer to Prevent Nab-paclitaxel Induced Toxic Neuropathy
Conjupro Biotherapeutics, Inc.
Phase 2 Withdrawn
NCT02215083 2017-07-12
L-glutamine Supplementation to Alleviate Symptoms of Taxane-Induced Neuropathy in Patients With Breast Cancer
Eastern Regional Medical Center
Phase 1 Withdrawn
NCT02606110 2017-07-12
Pilot Study Investigating the Use of the ReBuilder to Treat Chemotherapy Induced Peripheral Neuropathy in Patients With Breast Cancer
Eastern Regional Medical Center
Withdrawn